December 04, 2018
Sponsored by
Sophia Genetics

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

GenomeWebinar

Laboratory Director, Chief Genetic Officer, Co-founder,
Genotypos Science Labs

Clinical Application Product Manager
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dr. Pantelis Constantoulakis of Genotypos Science Labs will first discuss the utility of Clinical Exome Solution by Sophia Genetics in routine clinical research and diagnostics. He will also share details of the application’s efficacy in investigating complex and unsolved clinical cases. 

Next, Dr. Georgios Stamoulis of Sophia Genetics will introduce new features in Sophia DDM dedicated to prioritization and filtering strategies of variants detected with exome-size applications.

Sponsored by

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
11
Sponsored by
PerkinElmer

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.